SHARE
Cancer Immunotherapy Market

Cancer Immunotherapy - Global Market Outlook (2020-2028)

4.4 (21 reviews)
Published: April 2021 ID: SMRC20376
4.4 (21 reviews)
Published: April 2021 ID: SMRC20376

This report covers the impact of COVID-19 on this global market
Loading...

According to Stratistics MRC, the Global Cancer Immunotherapy Market is accounted for $104.20 billion in 2020 and is expected to reach $341.63 billion by 2028 growing at a CAGR of 16.0% during the forecast period. The rise in the occurrence of cancer and the increase in adoption of immunotherapy are the factors driving the market growth. However, the high cost of treatment is hampering the growth of the market.

Cancer immunotherapy is also known as biologic therapy. It helps in cancer treatment by improving the immunity of the body to fight against cancer. In this type of therapeutic antibodies and live viruses are introduced in the body that slows the increase of cancer cells.

Based on the application, the lung cancer segment is going to have lucrative growth during the forecast period due to the increasing number of patients suffering from lung diseases. By geography, Asia Pacific is going to have high growth during the forecast period due to the presence of a large patient base in several Asian nations.

Some of the key players profiled in the Cancer Immunotherapy Market include Amgen Inc., Astellas Pharma Inc., AstraZeneca plc, Bayer AG, Bristol-Myers Squibb , Celgene Corporation, Eli Lily and Co., F. Hoffmann-La Roche AG , Gristone Oncology, Inc, Janssen Global Services, LLC , Merck and Co. Inc., Novartis International AG, OSE Immunotherapeutics , Printegra, and Seattle Genetics Inc .

Mode of Administrations Covered:
• Intra Vesical
• Intravenous
• Oral
• Parenteral
• Topical

Types Covered:
• Adoptive Cell Transfer
• Adopted Cell Therapies (ACT) & Indoleamine-Pyrrole 2,3-Dioxygenase (IDO) Inhibitors
• Bacillus Calmette-Guerin (BCG)
• Cancer/Treatment Vaccines
• Cell Therapies
• Cellular Immunotherapy
• Checkpoint Inhibitors/Immune Checkpoint Inhibitors
• Immuno System Modulators
• Monoclonal Antibodies (mAbs)
• Non-specific immunotherapies & Adjuvants
• Oncolytic Viral Therapies  

Applications Covered:
• Blood Cancer 
• Breast Cancer 
• Childhood Cancer 
• Colorectal Cancer 
• Head and Neck Cancer
• Liver Cancer 
• Lung Cancer 
• Melanoma 
• Multiple Myeloma 
• Non-Small Cell Lung Cancer (NSCLC) 
• Ovarian Cancer 
• Pancreatic Cancer 
• Prostate Cancer 
• Skin Cancer 
• Stomach Cancer 
• Other Applications 
    
End Users Covered:
• Ambulatory Surgical Centers
• Cancer Speciality Centers/Research Centers
• Diagnostic Centers
• Homecare
• Hospitals & Clinics
• Households & Personalcare
• Medical Use
• Printing Inks 

Distribution Channels Covered:
• Online Pharmacy
• Offline Pharmacy   

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025 and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials